View Larger
Allison W. Kurian, M.D., M.Sc.
Academic Appointments
- Assistant Professor - Med Center Line, Medicine - Oncology
- Member, Stanford Cancer Institute
- Assistant Professor - Med Center Line, Health Research & Policy
Key Documents
Contact Information
-
Clinical Offices
Medical Oncology 875 Blake Wilbur Dr MC 5826 Stanford, CA 94305 Tel Work (650) 498-6000 Fax (650) 498-5150
- Academic Offices
Personal Information Email Tel (650) 498-6000Alternate Contact Oncology Clinic Tel Work 650-498-6000Not for medical emergencies or patient use
Professional Overview
Clinical Focus
- Cancer> Breast Cancer
- Cancer Genetics
- Medical Oncology
- Breast Cancer Risk
Administrative Appointments
- Advisory Committee, California HealthCare Foundation (2012 - present)
- Scientific Program Committee, Cancer Prevention and Epidemiology, American Society of Clinical Oncology (2011 - 2014)
- Scientific Program Committee, Quality Care Symposium, American Society of Clinical Oncology (2011 - present)
- Scientific Program Committee, Genetic and Molecular Epidemiology, American Association for Cancer Research (2011 - present)
- Board of Directors, Santa Clara County, American Cancer Society (2011 - present)
- Panel on Clinical Guideline Development for Genetic Risk of Breast and Ovarian Cancer, National Comprehensive Cancer Network (2009 - present)
Honors and Awards
- Top 12 publications funded by the Epidemiology and Genomics Research Program, National Cancer Institute (2012)
- New Clinical Investigator Award, Stanford Cancer Institute (2011)
- Translational Research Award, California Breast Cancer Research Program (2010)
- Jan Weimer Faculty Investigator Award for Breast Cancer Research, Stanford University (2008)
- Physician Faculty Scholars Award, Robert Wood Johnson Foundation (2008)
- Cornelius L. Hopper Research Abstract Award, California Breast Cancer Research Program (2007)
Professional Education
| Medical Education: | Harvard Medical School MA (1999) |
| M.Sc.: | Stanford University, Epidemiology (2006) |
| Board Certification: | Medical Oncology, American Board of Internal Medicine (2005) |
| Fellowship: | Stanford University School of Medicine CA (2005) |
| Board Certification: | Internal Medicine, American Board of Internal Medicine (2002) |
| Residency: | Massachusetts General Hospital MA (2002) |
Postdoctoral Advisees
Graduate & Fellowship Program Affiliations
Community and International Work
Scientific Focus
Current Research Interests
My research focuses on the genetics, epidemiology, prevention, and outcomes of women's cancers. This work is highly collaborative within the Stanford Divisions of Oncology and Epidemiology, with the Stanford Department of Radiology and Center for Biomedical Informatics Research, and with the Cancer Prevention Institute of California.
Ongoing projects include studies of the clinical epidemiology and outcomes of BRCA1/2 mutation-associated cancers, of breast cancer outcomes across diverse populations and treatment settings (the Oncoshare project), and of computer-based simulation modeling to evaluate new approaches to cancer screening and prevention.
Clinical Trials
- A Study of Pertuzumab in Combination With Herceptin (Trastuzumab) And Vinorelbine in First Line in Patients With Metastatic or Locally Advanced HER2-Positive Breast Cancer Recruiting
- A Study of Trastuzumab Emtansine, Paclitaxel, and Pertuzumab in Patients With HER2-Positive, Locally Advanced or Metastatic Breast Cancer Recruiting
- Factors Influencing Decision-Making About the Use of Chemoprevention in Women at Increased Risk for Breast Cancer Recruiting
- Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples Recruiting
- Phase II Veliparib or Placebo +/- Temozolomide or (Carboplatin & Paclitaxel) in Metastatic Breast CA Recruiting
Publications
- Patterns and predictors of breast cancer chemotherapy use in Kaiser Permanente Northern California, 2004-2007. Breast Cancer Res Treat. 2013; (1): 247-60
- Oncoshare: Lessons Learned from Building an Integrated Multi-institutional Database for Comparative Effectiveness Research. AMIA Annu Symp Proc. 2012: 970-8
- Online tool to guide decisions for BRCA1/2 mutation carriers. J Clin Oncol. 2012; (5): 497-506
- Breast cancer risk for noncarriers of family-specific BRCA1 and BRCA2 mutations: findings from the Breast Cancer Family Registry. J Clin Oncol. 2011; (34): 4505-9
- Lifetime risks of specific breast cancer subtypes among women in four racial/ethnic groups. Breast Cancer Res. 2010; (6): R99
- Survival analysis of cancer risk reduction strategies for BRCA1/2 mutation carriers. J Clin Oncol. 2010; (2): 222-31
Help